Influence of chemotherapy on the expression of p53, HER-2/neu and proliferation markers in ovarian cancer

By Nijman H.W.   Kenemans P.   Poort-Keesom R.J.J.   Verstraeten R.A.   Mensdorff-Pouilly S.   Verheijen R.H.M.   Melief C.J.M.   Hilgers J.   Meijer C.J.L.M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 83, Iss. 2, 1999-04 ,pp. : 201-206

Elsevier

Access to resources Recommend Favorite

P53 overexpression predicts endometrial carcinoma recurrence better than HER-2/neu overexpression

By Coronado P.J.   Vidart J.A.   Lopez-asenjo J.A.   Fasero M.   Furio-bacete V.   Magrina J.   Escudero M.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 98, Iss. 1, 2001-09 ,pp. : 103-108

Elsevier

Access to resources Recommend Favorite

Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer

By Kodama J.   Miyagi Y.   Seki N.   Tokumo K.   Mitsuo Yoshinouchi   Kobashi Y.   Okuda H.   Kudo T.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 82, Iss. 1, 1999-01 ,pp. : 107-110

Elsevier

Access to resources Recommend Favorite

An evaluation of prognostic factors in advanced ovarian cancer

By Brinkhuis M.   Meijer G.A.   Baak J.P.A.  

European Journal of Obstetrics and Gynecology and Reproductive Biology, Vol. 63, Iss. 2, 1995-12 ,pp. : 115-124

Elsevier

Access to resources Recommend Favorite

Origins of ovarian cancer: new insights

By Boyd Jeff  

Expert Review of Obstretrics and Gynecology, Vol. 6, Iss. 2, 2011-03 ,pp. : 111-113

Informa Healthcare

Access to resources Recommend Favorite